A Novel Chemometric Method for the Prediction of Human Oral Bioavailability
Orally administered drugs must overcome several barriers before reaching their target site. Such barriers depend largely upon specific membrane transport systems and intracellular drug-metabolizing enzymes. For the first time, the P-glycoprotein (P-gp) and cytochrome P450s, the main line of defense...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/6/6964 |
id |
doaj-5d3e3f3045ce4bd1b445e1abbd7786be |
---|---|
record_format |
Article |
spelling |
doaj-5d3e3f3045ce4bd1b445e1abbd7786be2020-11-24T23:15:51ZengMDPI AGInternational Journal of Molecular Sciences1422-00672012-06-011366964698210.3390/ijms13066964A Novel Chemometric Method for the Prediction of Human Oral BioavailabilityJinyou DuanYang LingYonghua WangHua YuChao HuangYan LiWuxia ZhangXue XuOrally administered drugs must overcome several barriers before reaching their target site. Such barriers depend largely upon specific membrane transport systems and intracellular drug-metabolizing enzymes. For the first time, the P-glycoprotein (P-gp) and cytochrome P450s, the main line of defense by limiting the oral bioavailability (OB) of drugs, were brought into construction of QSAR modeling for human OB based on 805 structurally diverse drug and drug-like molecules. The linear (multiple linear regression: MLR, and partial least squares regression: PLS) and nonlinear (support-vector machine regression: SVR) methods are used to construct the models with their predictivity verified with five-fold cross-validation and independent external tests. The performance of SVR is slightly better than that of MLR and PLS, as indicated by its determination coefficient (<em>R</em><sup>2</sup>) of 0.80 and standard error of estimate (SEE) of 0.31 for test sets. For the MLR and PLS, they are relatively weak, showing prediction abilities of 0.60 and 0.64 for the training set with SEE of 0.40 and 0.31, respectively. Our study indicates that the MLR, PLS and SVR-based <em>in silico</em> models have good potential in facilitating the prediction of oral bioavailability and can be applied in future drug design.http://www.mdpi.com/1422-0067/13/6/6964oral bioavailabilityquantitative structure activity relationshipcytochrome P4503A4 and P4502D6P-glycoprotein |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jinyou Duan Yang Ling Yonghua Wang Hua Yu Chao Huang Yan Li Wuxia Zhang Xue Xu |
spellingShingle |
Jinyou Duan Yang Ling Yonghua Wang Hua Yu Chao Huang Yan Li Wuxia Zhang Xue Xu A Novel Chemometric Method for the Prediction of Human Oral Bioavailability International Journal of Molecular Sciences oral bioavailability quantitative structure activity relationship cytochrome P4503A4 and P4502D6 P-glycoprotein |
author_facet |
Jinyou Duan Yang Ling Yonghua Wang Hua Yu Chao Huang Yan Li Wuxia Zhang Xue Xu |
author_sort |
Jinyou Duan |
title |
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability |
title_short |
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability |
title_full |
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability |
title_fullStr |
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability |
title_full_unstemmed |
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability |
title_sort |
novel chemometric method for the prediction of human oral bioavailability |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2012-06-01 |
description |
Orally administered drugs must overcome several barriers before reaching their target site. Such barriers depend largely upon specific membrane transport systems and intracellular drug-metabolizing enzymes. For the first time, the P-glycoprotein (P-gp) and cytochrome P450s, the main line of defense by limiting the oral bioavailability (OB) of drugs, were brought into construction of QSAR modeling for human OB based on 805 structurally diverse drug and drug-like molecules. The linear (multiple linear regression: MLR, and partial least squares regression: PLS) and nonlinear (support-vector machine regression: SVR) methods are used to construct the models with their predictivity verified with five-fold cross-validation and independent external tests. The performance of SVR is slightly better than that of MLR and PLS, as indicated by its determination coefficient (<em>R</em><sup>2</sup>) of 0.80 and standard error of estimate (SEE) of 0.31 for test sets. For the MLR and PLS, they are relatively weak, showing prediction abilities of 0.60 and 0.64 for the training set with SEE of 0.40 and 0.31, respectively. Our study indicates that the MLR, PLS and SVR-based <em>in silico</em> models have good potential in facilitating the prediction of oral bioavailability and can be applied in future drug design. |
topic |
oral bioavailability quantitative structure activity relationship cytochrome P4503A4 and P4502D6 P-glycoprotein |
url |
http://www.mdpi.com/1422-0067/13/6/6964 |
work_keys_str_mv |
AT jinyouduan anovelchemometricmethodforthepredictionofhumanoralbioavailability AT yangling anovelchemometricmethodforthepredictionofhumanoralbioavailability AT yonghuawang anovelchemometricmethodforthepredictionofhumanoralbioavailability AT huayu anovelchemometricmethodforthepredictionofhumanoralbioavailability AT chaohuang anovelchemometricmethodforthepredictionofhumanoralbioavailability AT yanli anovelchemometricmethodforthepredictionofhumanoralbioavailability AT wuxiazhang anovelchemometricmethodforthepredictionofhumanoralbioavailability AT xuexu anovelchemometricmethodforthepredictionofhumanoralbioavailability AT jinyouduan novelchemometricmethodforthepredictionofhumanoralbioavailability AT yangling novelchemometricmethodforthepredictionofhumanoralbioavailability AT yonghuawang novelchemometricmethodforthepredictionofhumanoralbioavailability AT huayu novelchemometricmethodforthepredictionofhumanoralbioavailability AT chaohuang novelchemometricmethodforthepredictionofhumanoralbioavailability AT yanli novelchemometricmethodforthepredictionofhumanoralbioavailability AT wuxiazhang novelchemometricmethodforthepredictionofhumanoralbioavailability AT xuexu novelchemometricmethodforthepredictionofhumanoralbioavailability |
_version_ |
1725589244006629376 |